Clover Biopharmaceuticals
Chengdu · Founded 2007
About Clover Biopharmaceuticals
Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. Clover is utilizing its proprietary Trimer-Tag© technology platform to develop novel biologics targeting trimerization-dependent pathways. Additionally, Clover is leveraging its in-house cGMP biomanufacturing capabilities to develop select biosimilars.
Company Facts
- Founded: 2007
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $1K – $10K
- Total funding: $343.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2021)
- Ticker: hkg:2197
- Website: http://www.cloverbiopharma.com/
- Phone: +86 (028)85336933
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/clover-biopharmaceuticals-44699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.